share_log

Silence Therapeutics Shareholders Approve Delisting From AIM

Silence Therapeutics Shareholders Approve Delisting From AIM

沉默治疗公司股东批准从AIM退市
Dow Jones Newswires ·  2021/11/01 13:52

By Joe Hoppe

乔·霍普(Joe Hoppe)著

Silence Therapeutics PLC said Monday that its shareholders voted to approve the cancellation of its listing on London's junior AIM, keeping a single listing on New York's Nasdaq.

沉默治疗公司周一表示,其股东投票批准取消其在伦敦初级AIM的上市,保留在纽约纳斯达克(Nasdaq)的单一上市。

The medical company said on Oct. 15 that it would seek shareholder approval to delist, adding that the move would enhance liquidity in its American Depositary Shares and increase U.S. investors' willingness to invest in the company.

这家医疗公司10月15日表示,将寻求股东批准退市,并称此举将增强其美国存托股份的流动性,并提高美国投资者投资该公司的意愿。

The last day of trading is expected to be Nov. 29.

最后一个交易日预计是11月29日。

Write to Joe Hoppe at joseph.hoppe@wsj.com

写信给乔·霍普(joseph.hop pe@wsj.com)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发